BDX:NYSE (USA) Also trade in: Germany Mexico Switzerland UK

Becton, Dickinson and Co

$ 227.89 2.02 (0.89%)
Volume: 2,542,740 Avg Vol (1m): 1,192,554
Market Cap $: 61.32 Bil Enterprise Value $: 81.44 Bil
P/E (TTM): 70.12 P/B: 2.87
Earnings Power Value -19.52
Net Current Asset Value -91.39
Tangible Book -67.51
Projected FCF 126.94
Median P/S Value 171.65
Graham Number 0
Peter Lynch Value 21.48
DCF (FCF Based) 85.87
DCF (Earnings Based) 34.78
YTD (-%)

Financial Strength : 5/10

Current vs industry vs history
Cash-to-Debt 0.05
Equity-to-Asset 0.40
Debt-to-Equity 0.98
Debt-to-EBITDA 4.44
Interest Coverage 3.66
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.98
DISTRESS
GREY
SAFE
Beneish M-Score -2.45
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 3.67%
WACC 8.87%

Profitability & Growth : 8/10

Current vs industry vs history
Operating Margin % 15.42
Net Margin % 6.13
ROE % 4.22
ROA % 1.93
ROC (Joel Greenblatt) % 34.20
3-Year Total Revenue Growth Rate 15.80
3-Year Total EBITDA Growth Rate 24.50
3-Year EPS w/o NRI Growth Rate -43.60

» BDX's 30-Y Financials

Financials (Next Earnings Date: 2019-05-09)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:BDX

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 339112    SIC : 3841
Compare NYSE:BAX NAS:ILMN XPAR:EI TSE:4543 OCSE:COLO B NYSE:WAT NYSE:MTD NYSE:RMD TSE:7733 NAS:XRAY NYSE:COO XSWX:STMN NAS:HOLX NYSE:STE SZSE:002294 NYSE:WST NYSE:HRC NAS:ICUI NAS:PODD NYSE:CMD
Traded in other countries BOX.Germany 0R19.UK
Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. International revenue accounts for less than 50% of the company's business. With CareFusion, BD has entered into medical systems (such as infusion pumps and ventilators) as well as procedural solutions businesses. The Bard deal gives the company a presence in urology, vascular, and oncology.

Ratios

Current vs industry vs history
PE Ratio (TTM) 70.12
Forward PE Ratio 18.83
N/A
PE Ratio without NRI 70.12
Price-to-Owner-Earnings 26.36
PB Ratio 2.87
PS Ratio 3.64
Price-to-Free-Cash-Flow 32.68
Price-to-Operating-Cash-Flow 22.31
EV-to-EBIT 32.58
EV-to-EBITDA 17.15
EV-to-Revenue 4.77
PEG Ratio 9.22
Shiller PE Ratio 43.65
Current Ratio 0.97
Quick Ratio 0.62
Days Inventory 101.53
Days Sales Outstanding 47.41
Days Payable 43.04

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.33
Dividend Payout Ratio 0.89
3-Year Dividend Growth Rate (Per Share) 7.70
Forward Dividend Yield % 1.35
N/A
Yield-on-Cost (5-Year) % 2.06
3-Year Share Buyback Rate -8.40

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.80
Price-to-DCF (Earnings Based) 6.55
Price-to-Median-PS-Value 1.32
Price-to-Peter-Lynch-Fair-Value 10.61
Earnings Yield (Joel Greenblatt) % 3.07
Forward Rate of Return (Yacktman) % 9.55

More Statistics

Revenue (TTM) (Mil) $ 17,062
EPS (TTM) $ 3.25
Beta 1.4
Volatility % 25.77
52-Week Range $ 208.62 - 265.87
Shares Outstanding (Mil) 269.06

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N